Biologics

Nanoparticle Drug Delivery Aims to Control Pancreatic Tumor and Inhibit Escape Pathways

By

Use of a nanoparticle to deliver drugs may reduce tumors and suppress metastatic escape. These efforts offer a way to control drug release over space and time while reducing systemic drug exposure and the associated side effects.

New G-CSF approved in Europe, in clinical trials in the U.S.

New G-CSF approved in Europe, in clinical trials in the U.S.

By

I am hearing there is a new granulocyte colony-stimulating factor (G-CSF) coming out on the market. What can you tell us about this product?

Bacterial biosurgery promising for reducing size of inoperable tumors

By

Deep within most tumors lie areas that remain untouched by chemotherapy and radiation. These areas lack the blood and oxygen needed for traditional therapies to work, but provide the perfect target for a new cancer treatment.

Powerful new way to treat HER2-positive breast cancer validated

Powerful new way to treat HER2-positive breast cancer validated

By

HER2-positive breast cancer typically develops resistance to Herceptin within several years. researchers have found a means of inhibiting another protein whose expression is also upregulated in HER2-positive breast cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs